(Date:11/24/2009)... The FBI recently approved ...ratories participating in or generating DNA record... Madison, WI USA (PRWEB) -- The FBI r... System for use by laboratories participating in,...ndex System (NDIS). NDIS currently contains more t...
(Date:11/24/2009)...,, TSXVENTURE:HTL , TORONTO,Nov.24/PRNewsw...rlyCalottoCapitalInc.,aleadingproviderofadvancedla...ertilityclinicmarkets,todayreportedoperationalandf...2009. , ,Q32009Highlights,-Revenuewas$1.46millio...inwas66.3percentcomparedwith66.1percentinQ3,2008,-...
(Date:11/24/2009)...,, SANDIEGO,Nov.24,2009/PRNewswire-FirstCall/--... todaythatthecompanyisscheduledtopresentatthePiper...009at11:30a.m.EasternTime(8:30a.m.PacificTime)atth...President andChiefExecutiveOfficer,isscheduledtopr...velopmentanddiscoveryprograms. ,, Aliveaudioweb...
(Date:11/24/2009)...,, BOZEN,Italy,November24/PRNewswire/--HealthRo...intventurewithagroupofselected,investors.Thisrecen...ameHealthRoboticsCanada,Inc.andwillmarket,install,...pt,whichincludesthe,revolutionaryproductofferingsi...ticsCanadaInc.willalsoprovideassistanceonan"asneed...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2... Feb. 24 /PRNewswire-FirstCall/ - Angiotech Pharma...bal specialty pharmaceutical and medical device co... quarter and year end conference call. The call wi...day, March 5, 2009. , , , Dial information for...d, and is as follows:, North America (toll-f...
...s Effect on Reduction of Exacerbations is the Attr... Decisions, According to a New Report from Decisio... Resources, one of the world,s leading research an... issues, finds that Novartis/Schering-Plough,s ind...bicort as Decision Resources, proprietary clinical...
... Highlighted by Cinryze(TM) [C1 Inhibitor (human)]...roPharma Incorporated (Nasdaq: VPHM ) reported t...and year ended December 31, 2008. , , Key events ...: , , , Closed on acquisition of Lev Pha...Initiated commercial launch of Cinryze for routine...
Other Biology Technology:Novartis/Schering-Plough's Drug Will Replace AstraZeneca's Symbicort as Decision Resources' Clinical Gold Standard by 2012 for the Treatment of Asthma 2ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 2ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 3ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 4ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 5ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 6ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 7ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 8ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 9ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 10ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 11ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 12...erimental procedure that dramatically strengthens ...ould offer new hope to sufferers of muscle-wasting... according to researchers from the University of N...e has been successfully used to regrow muscles in ...ue-based illnesses in humans such as in the liver,...
... professionals send genes and healthy cells on the...or example, repair tissue damage to arteries. But ...tities? Scientists of the PTB have developed a hig...ciency of this therapy can be investigated: Small ...ed gene or on the planted cell can with the aid of...
...g to shed new light on HIV,s ability to survive in...e of Allergy and Infectious Diseases at the NIH ha...DS research team at the New York University Colleg... of HIV replication that involves cooperation betw..., an Assistant Professor of Basic Science and Cran...
Other Biology News:Stem cell breakthrough gives new hope to sufferers of muscle-wasting diseases 2NYU College of Dentistry awarded $1.9 million NIH grant for HIV research 2Rabbit Anti-Human Ets-1 Antibody, Unconjugated from Spring Bioscience
Anti-Desmoglein 1 Monoclonal Antibody, Unconjugated, Clone 27B2 from Invitrogen
Secure-Seal spacer, one well, 20 mm diameter, 0.12 mm deep *set of 100* from Molecular Probes (Invitrogen)
Goat Anti-Human Synphilin 1 Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: